1. |
Henry JM, Barnett JP, Bennett M, et al. 卒中病理生理, 诊断及其治疗[M]. 高旭光,译. 3版. 沈阳: 辽宁科学技术出版社,2001: 13-15.
|
2. |
Korybalska K, Kawka E, Breborowicz A, et al. Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury[J]. J Physiol Pharmacol, 2012, 63(4): 389-395.
|
3. |
他汀类药物预防缺血性卒中/短暂性脑缺血发作专家组. 他汀类药物预防缺血性卒中/短暂性脑缺血的专家建议[J]. 中华内科杂志, 2007, 46(1): 8l-82.
|
4. |
van Schie RM, Verhoef TI, Boejharat SB, et al. Evaluation of the effect of statin use on the acenocoumarol and phenprocoumon maintenance dose[J]. Drug Metabol Drug Interact, 2012, 27(4): 229-234.
|
5. |
Barth JD. An update on carotid ultrasound measurement of intima-media thickness[J]. Am J Cardiol, 2002, 89(4A): 32B-38B.
|
6. |
邹艳华, 戈晓华. 颈动脉超声多普勒实习手册[M]. 北京: 学苑出版社, 1996: 6-7.
|
7. |
Kadoglou NP, Sailer N, Moumtzouoglou A, et al. Adipokines: a novel link between adiposity and carotid plaque vulnerability[J]. Eur J Clin Invest, 2012, 42(12): 1278-1286.
|
8. |
Grundy SM,Cleeman JI,Merz CN,et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines[J].Circulation, 2004, 110 (2): 227-239.
|
9. |
Bo?entowicz-Wikarek M, Koce?ak P, Smertka M, et al. Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis-guidelines vs. reality[J]. Pharmacol Rep, 2012, 64(2): 377-385.
|
10. |
Pramanik S, Das AK, Chakrabarty M, et al. Efficacy of alternate-day versus everyday dosing of atorvastatin[J]. Indian J Pharmacol, 2012, 44(3): 362-365.
|
11. |
Kitamura A, Iso H, Imano H,et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men[J]. Stroke, 2004, 35(12): 2788-2794.
|
12. |
Eussen SR, Rompelberg CJ, Klungel OH, et al. Modeling approach to simulate reductions in LDL cholesterol levels after combined intake of statins and phytosterols/-stanols in humans[J]. Lipids Health Dis, 2011,10: 187.
|